Squadron Capital Management LLC
Source: SEC Form 13F · as of Mar 2026Squadron Capital Management LLC holds 19 biotech & pharma companies tracked by BioSniper, totaling $199.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$199.3M
BioSniper AIPage evidence connected
Prepared research question
What matters most for RELMADA THERAPEUTICS, INC. (RLMD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| RLMDRELMADA THERAPEUTICS, INC. | 8,474,571 | $59.0M |
| COGTCogent Biosciences, Inc. | 787,492 | $30.3M |
| KALVKalVista Pharmaceuticals, Inc. | 985,100 | $19.8M |
| KODKodiak Sciences Inc. | 380,000 | $14.5M |
| ABVXAbivax SA | 130,000 | $14.5M |
| NKTRNEKTAR THERAPEUTICS | 125,000 | $9.0M |
| ZNTLZentalis Pharmaceuticals, Inc. | 3,631,000 | $8.5M |
| MAZEMaze Therapeutics, Inc. | 257,500 | $7.7M |
| RLAYRelay Therapeutics, Inc. | 672,500 | $6.7M |
| CCCCC4 Therapeutics, Inc. | 2,250,000 | $5.9M |
| GHRSGH Research PLC | 325,000 | $4.6M |
| PMNProMIS Neurosciences Inc. | 324,977 | $4.1M |
| LPCNLipocine Inc. | 450,000 | $3.6M |
| IVAInventiva S.A. | 535,000 | $3.0M |
| ALXOALX ONCOLOGY HOLDINGS INC | 1,460,000 | $2.9M |
| CNTXContext Therapeutics Inc. | 1,100,000 | $2.9M |
| KTTAPasithea Therapeutics Corp. | 2,100,000 | $1.6M |
| HOWLWerewolf Therapeutics, Inc. | 563,535 | $469K |
| NEUPNeuphoria Therapeutics Inc. | 76,728 | $312K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.